Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2024

Mar 25, 2024

33298_dirs_2024-03-25_6a028876-4f40-432c-b463-f14a082b81de.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2024-03-21

Reporting Person: Yecies Eric Harold (General Counsel & CCO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-03-21 Common Stock A 56250 Acquired 271250 Direct

Footnotes

F1: Performance shares vested on March 21, 2024.

F2: The total shares beneficially owned reflect a correction to previously reported ownership.